SAMUEL CHRISTENSEN: Open Payments
NPI 1477988467 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$666 in 28 payments from 10 companies in 2025. Trend: 2023 $287 · 2024 $489 · 2025 $666
Food & beverage: $666
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 2 | $152 |
| Arcutis Biotherapeutics, Inc. | 13 | $151 |
| Janssen Biotech, Inc. | 3 | $150 |
| Lilly USA, LLC | 3 | $55 |
| Surgenex LLC | 2 | $43 |
| LEO Pharma Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| ABBVIE INC. | 1 | $25 |
| GENZYME CORPORATION | 1 | $19 |
| Incyte Corporation | 1 | $18 |
Products named: Bimzelx, Zoryve, TREMFYA, TALTZ, SurGraft, ANZUPGO, Sotyktu, SKYRIZI.
Industry payments across OR — which companies pay providers there.
